Skip to main content

Precision Medicine

Precision Medicine
By Bill Siwicki | 01:22 pm | January 05, 2018
The company wants to help employer groups offer genetic testing to employees through confidential consults with providers and includes a telemedicine option.
Analytics
By Mike Miliard | 11:53 am | January 05, 2018
The Cancer Center will deploy data and analytics tools for clinical research and personalized treatment at the new Miami Cancer Institute.
Precision Medicine
By Tom Sullivan | 10:44 am | January 05, 2018
The tech giants both participated in a VC round and three days later, each had also invested in another emerging company with cutting-edge technology tailored for healthcare.
Precision Medicine
By Bernie Monegain | 01:32 pm | January 04, 2018
The aim is to create a universal blood test that detects autoimmune disorders, cancer, diseases and infections, the companies said.
Precision Medicine
By Jessica Davis | 05:24 pm | January 02, 2018
The National Institutes of Health’s Genomic Working Group said researchers should build the program in a systemic way before reaching the planned 1 million participants.
Precision Medicine
By Bernie Monegain | 01:25 pm | January 02, 2018
Company will use the $58 million round of financing to advance its cloud-based platform for genomics and biomedical datasets.
Precision Medicine
By Bernie Monegain | 02:58 pm | December 29, 2017
Health systems, researchers, startups, app developers and EHR makers are all taking critical roles in growing the promise of precision medicine.
Analytics
By Mike Miliard | 04:20 pm | December 18, 2017
Michael Draugelis says artificial intelligence has big potential to drive analytics on varied and voluminous clinical data – but care must be taken to enable consistent and repeatable performance.
Electronic Health Records
By Mike Miliard | 11:22 am | December 18, 2017
The hospital tapped FHIR-based alerts to deliver recommendations about genomics and genetic testing without bogging down doctors with too many extra clicks.
Precision Medicine
By Bernie Monegain | 01:10 pm | December 15, 2017
Siemens Healthineers bought Fast Track Diagnostics to build out its precision medicine technologies. Adding Fast Track Diagnostics molecular-testing technologies enables hospitals to target conditions such as respiratory infections, gastroenteritis, meningitis, hepatitis, infections of the immunosuppressed, tropical diseases, sexually transmitted diseases, and early childhood diseases. [Also: Precision med is about to have its breakout moment ] The tests can detect more than 140 viruses, bacteria, parasites, and fungi. Siemens Healthineers head of Molecular Diagnostics Fernando Beils said that the acquisition expands its precision medicine portfolio, while Fast Track Diagnostics CEO Bill Carman added that combining the technologies can help customers improve outcomes for patients. Fast Track has about 80 employees in Luxembourg, Malta and India. Siemens did not disclose terms of the acquisition. Twitter: @Bernie_HITN Email the writer: bernie.monegain@himssmedia.com